India, U.S. Set High-Level Talks Over Drug Quality, IP Issues
This article was originally published in PharmAsia News
Executive Summary
U.S. pharmaceutical companies will have a chance to make their case about drug quality and patent issues when India Prime Minister Narendra Modi holds a teleconference with them on his American trip this month.